CoChat

Oncogenic K-ras “addiction” and synthetic lethality

Open access
Singh, Anurag, Settleman, Jeff · 2009 · Cell Cycle
Cited by 44

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Mutational activation of the K-ras gene is a frequent oncogenic event in human cancers, associated with poor clinical prognosis and resistance to treatment.Despite efforts to develop therapeutics that target K-ras or its downstream effector molecules, clinical benefit in this setting has not yet been achieved.An alternative approach to K-ras mutant cancers involves the identification of genes that selectively drive the maintenance of tumors that are "addicted" to or dependent on mutant K-ras.Disruption of these genes would result in "synthetic lethality" specifically in cancer cells driven by mutant K-ras, thereby potentially sparing non-tumor cells.Through this approach, three recent reports have identified PLK1, STK33, SYK, RON and integrin β6 as previously unappreciated pharmacologically tractable targets in the setting of K-ras activation, which drive growth and survival selectively in K-ras-dependent cancer cells.K-ras mutations are among the most frequent oncogenic events in human cancers, most often seen in adenocarcinomas of the lung, pancreas and colon, 1 and K-ras mutant cancers are notoriously refractory to available therapies.K-ras is a small GTPase with binary molecular switch functionality, which upon activation engages effectors such as the Raf and PI3 kinases, thereby stimulating signaling cascades 2 that can impact proliferation, apoptosis and differentiation. 3K-ras mutational activation in mouse models of tumorigenesis drives neoplastic and malignant progression. 4Thus, mutational activation of K-ras is a well established tumor-initiating event, underscored by the observation that K-ras mutations arise in early pre-neoplastic lesions. 5,6 However, it is unclear whether K-ras activity is required for tumor maintenance during later stages of malignant progression.Transgenic mouse models of Myc-or Ras-induced oncogenesis, in which these

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/cc.8.17.9336

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Singh, A., & Settleman, J.
Venue
Cell Cycle
Published
2009-09
Volume
8
Issue
17
Pages
2676-2678
ISSN
  • 1538-4101 (ISSN-L)
  • 1551-4005
OpenAlex
W2020201038
Cited by
44
References
2
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.